Matches in Wikidata for { <http://www.wikidata.org/entity/Q107501361> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q107501361 description "clinical trial" @default.
- Q107501361 description "ensayo clínico" @default.
- Q107501361 description "ensayu clínicu" @default.
- Q107501361 description "klinik çalışma" @default.
- Q107501361 description "klinisch onderzoek" @default.
- Q107501361 description "клінічне випробування" @default.
- Q107501361 description "临床试验" @default.
- Q107501361 name "Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study" @default.
- Q107501361 name "Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study" @default.
- Q107501361 type Item @default.
- Q107501361 label "Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study" @default.
- Q107501361 label "Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study" @default.
- Q107501361 prefLabel "Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study" @default.
- Q107501361 prefLabel "Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study" @default.
- Q107501361 P1132 Q107501361-7B639948-0B9F-414E-9107-3C168D5FDF63 @default.
- Q107501361 P1476 Q107501361-99E00E8E-17D1-410E-8A32-431BFF285963 @default.
- Q107501361 P17 Q107501361-EB57467D-9A30-4497-B1C3-92EB272C8940 @default.
- Q107501361 P2899 Q107501361-E611036F-51E8-4771-B6A3-5B65AB1667D6 @default.
- Q107501361 P3098 Q107501361-EEDBD403-49B1-4039-92D9-337BC622D819 @default.
- Q107501361 P31 Q107501361-A3EC8510-50DB-4DE7-88C3-89F2776B8E80 @default.
- Q107501361 P4135 Q107501361-EFE9624B-BD02-4578-875B-37E2AA0E9F93 @default.
- Q107501361 P580 Q107501361-0D0F5B21-0F69-4F7F-9E6F-9500018EF5BC @default.
- Q107501361 P582 Q107501361-47D98CF8-9AA7-422E-B975-D6B3C303AC90 @default.
- Q107501361 P8005 Q107501361-5DFBE123-6D05-4D60-B515-6041215E32D3 @default.
- Q107501361 P8363 Q107501361-1F0CD701-F335-436A-ACE5-D3E4C503F61C @default.
- Q107501361 P1132 "+800" @default.
- Q107501361 P1476 "Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study" @default.
- Q107501361 P17 Q414 @default.
- Q107501361 P2899 "+18" @default.
- Q107501361 P3098 "NCT04954235" @default.
- Q107501361 P31 Q30612 @default.
- Q107501361 P4135 "+79" @default.
- Q107501361 P580 "2021-05-22T00:00:00Z" @default.
- Q107501361 P582 "2021-07-05T00:00:00Z" @default.
- Q107501361 P8005 Q76649708 @default.
- Q107501361 P8363 Q818574 @default.